CTLT vs KALV
CTLT (CTLT) versus Kalvista Pharmaceuticals Inc (KALV) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
CTLT does not have a complete income-statement cache yet.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
KALV currently screens at market cap $1.44B.
Not investment advice. Open the CTLT and KALV stock pages for the full models.
Not investment advice.